Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | S100A2 |
| Upstream (Parents) |
|---|
| (<<) S100A6 → S100A2 |
| (<<) FHL2 → S100A2 |
| (<<) LAMC2 → S100A2 |
| Downstream (Children) |
|---|
| S100A2 → RASAL1 (>>) |
| S100A2 → CST6 (>>) |
| S100A2 → ABCA4 (>>) |
| S100A2 → OLFM4 (>>) |
| S100A2 → SOSTDC1 (>>) |
| S100A2 → MMP1 (>>) |
| S100A2 → KRT6A (>>) |
| S100A2 → KRT6B (>>) |
| S100A2 → KRT17 (>>) |
| S100A2 → MMP10 (>>) |
| S100A2 → MIA (>>) |
| S100A2 → KRT15 (>>) |
| S100A2 → MMP7 (>>) |
| S100A2 → CCND1 (>>) |
| S100A2 → RHCG (>>) |
